STRUCTURAL REQUIREMENTS FOR NEUROPEPTIDE-Y IN MAST-CELL AND G-PROTEIN ACTIVATION

被引:34
作者
MOUSLI, M
TRIFILIEFF, A
PELTON, JT
GIES, JP
LANDRY, Y
机构
[1] UNIV LOUIS PASTEUR STRASBOURG 1,INSERM,U425,ILLKIRCH GRAFFENS,FRANCE
[2] MARION MERRELL DOW RES INST,STRASBOURG,FRANCE
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1995年 / 289卷 / 01期
关键词
MAST CELL; NEUROPEPTIDE Y; CIRCULAR DICHROISM SPECTRUM; HETEROTRIMERIC G PROTEIN; BENZALKONIUM CHLORIDE; PERTUSSIS TOXIN; (RAT); (HUMAN);
D O I
10.1016/0922-4106(95)90177-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Incubation of neuropeptide Y or its C-terminal fragments with rat peritoneal mast cells resulted in a dose-dependent histamine release. Fragment 18-36 of neuropeptide Y was the most biologically active peptide. EC(25) value on rat mast cells was 7.2 +/- 2.2 nM. Neuropeptide Y was also able to induce a flare response after intradermal injection in humans. The histamine releasing effects of neuropeptide Y related peptides were greatly inhibited by pretreatment of rat mast cells with pertussis toxin or benzalkonium chloride. Neuropeptide Y and C-terminal related peptides also stimulated the GTPase activity of purified heterotrimeric G proteins in a dose-dependent manner from 1 to 50 mu M. Binding studies with [I-125]neuropeptide Y were unable to provide evidence for the presence of specific binding sites on the surface of mast cells. The alpha helical conformation of neuropeptide Y fragments was studied by measuring the circular dichroism spectra. Neuropeptide Y-(18-36) was the smallest fragment having a strong helical conformation. Our results demonstrate that neuropeptide Y activates mast cells through a non-specific process leading to G protein activation.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 33 条
[1]   ACTIVATION OF EXOCYTOSIS BY THE HETEROTRIMERIC-G PROTEIN-G(I3) [J].
ARIDOR, M ;
RAJMILEVICH, G ;
BEAVEN, MA ;
SAGIEISENBERG, R .
SCIENCE, 1993, 262 (5139) :1569-1572
[2]   MODULATION OF NEUROGENIC INFLAMMATION - NOVEL APPROACHES TO INFLAMMATORY DISEASE [J].
BARNES, PJ ;
BELVISI, MG ;
ROGERS, DF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (05) :185-189
[3]  
BOUBLIK J, 1989, INT J PEPT PROT RES, V33, P11
[4]   ROLE OF PHOSPHOLIPASE-A2 AND G-PROTEINS IN THE IGE-DEPENDENT ACTIVATION OF MAST-CELLS AND MACROPHAGES [J].
BRONNER, C ;
COTHENET, V ;
MONTE, D ;
JOSEPH, M ;
LANDRY, Y ;
CAPRON, A .
AGENTS AND ACTIONS, 1990, 30 (1-2) :95-97
[5]  
BUEB JL, 1990, MOL PHARMACOL, V38, P816
[6]  
EMADIKHIAV B, 1994, IN PRESS EUR J PHARM
[7]   THE MECHANISM OF INHIBITION OF ALKYLAMINES ON THE MAST-CELL PEPTIDERGIC PATHWAY [J].
FISCHER, T ;
BRONNER, C ;
LANDRY, Y ;
MOUSLI, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1176 (03) :305-312
[8]  
FOREMAN JC, 1981, BRIT J PHARMACOL, V73, pP207
[9]  
FUKUOKA Y, 1990, J IMMUNOL, V145, P1851
[10]   NEUROPEPTIDE-Y AND TRUNCATED NEUROPEPTIDE-Y ANALOGS EVOKE HISTAMINE-RELEASE FROM RAT PERITONEAL MAST-CELLS - A DIRECT EFFECT ON G-PROTEINS [J].
GRUNDEMAR, L ;
KRSTENANSKY, JL ;
HAKANSON, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 258 (1-2) :163-166